m+Medelevator.RU
← Поиск публикаций
Current pharmaceutical biotechnology · 2026

Pisum sativum L. Peel Extract Based Biogenic Silver Nanoparticles as Antibiotic Adjuvants to Reverse Multidrug Resistance in Bacteria.

СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Batool Salma, Shahid Izzah, Iftikhar Moaiza, Haider Burhan, Deeba Farah, Saleem Rahman Shah Zaib

Аннотация

INTRODUCTION: Rapid spread of antimicrobial drug resistance is alarming and demands a sustainable solution. Green synthesis of silver nanoparticles can pave the way for the development of adjuvants that can help overcome bacterial drug resistance.

METHODS: In the current study, green synthesis of silver nanoparticles utilizing pea (Pisum sativum) peels and their evaluation against multidrug-resistant (MDR) bacterial pathogens has been proposed. Pea peels were extracted and analyzed for antioxidant potential by non-enzymatic DPPH assay. The extract was used to prepare silver nanoparticles (gAgNPs) characterized using UV-VIS spectroscopy, SEM, FTIR, and zeta sizer, and evaluated for antibacterial activity.

RESULTS: The SEM showed that the gAgNPs were spherical with a size of 59.24 nm ± 0.3, and the zeta sizer gave a PDI of 0.2. As adjuvants, these gAgNPs in combination with vancomycin showed a superior antibacterial activity against vancomycin-resistant E. faecalis (zone of inhibition= 66 mm ± 0.41) and vancomycin-resistant P. aeruginosa (35 mm ± 1.41) as compared to vancomycin. Hemolysis was IC50= 998.44 μg/mL, creating a therapeutic window for IC50 =5 μg/mL, effective against human pathogens.

CONCLUSION: This study suggests these gAgNPs could be a good lead to work as adjuvants with vancomycin against vancomycin-resistant Gram-positive and Gram-negative clinical bacteria and thus warrants further studies.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты